Simini Technologies Inc.
$34,263.60
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada
SMN-023 is new a topical therapy for canine atopic dermatitis. This study is designed to show proof of concept that SMN-023 can be the first pharmaceutical approved as a maintenance therapy to delay...